Large scale revenue Ilko Pharmaceuticals reports revenue in the high hundreds of millions to over a billion dollars range, indicating significant market presence and potential capacity for high-value contract manufacturing, co-development, or exclusive supply agreements.

Strategic locations Operations span multiple hubs with a flagship production plant in Konya, a headquarters in Istanbul, and R&D in Ankara, suggesting opportunities for regional partnerships, localized supply chains, and targeted sales campaigns across Turkey and neighboring regions.

R&D strength An established R&D center at Hacettepe University signals a capability for collaborative innovation and early-access product development, opening doors for joint research programs, technology licensing, and custom formulation partnerships.

Tech and data readiness Adoption of ERP and modern tech stack including SAP, iCIMS, IQVIA, and analytics tools indicates mature operations and data-driven decision-making, making them receptive to advanced manufacturing services, digital health partnerships, and analytics-enabled supply solutions.

Group backing As a subsidiary of Selçuklu Holding with diversified institutions, Ilko benefits from strong corporate backing, providing credibility for large, multi-year contracts, risk-sharing arrangements, and expanded channel opportunities through the holding network.